Enteroporc AC inj. susp. (lyoph. + solv.) i.m. vial

Country: Belgium

Language: English

Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Active ingredient:

Clostridium Perfringens Type A/C, Beta2 Toxoid ; Clostridium Perfringens Type A/C, Alfa Toxoid ; Clostridium Perfringens Type A/C, Beta1 Toxoid

Available from:

IDT Biologika GmbH

ATC code:

QI09AB12

INN (International Name):

Clostridium Perfringens Type A/C, Alfa Toxoid; Clostridium Perfringens Type A/C, Beta1 Toxoid; Clostridium Perfringens Type A/C, Beta2 Toxoid

Pharmaceutical form:

Lyophilisate and solvent for suspension for injection

Composition:

Clostridium Perfringens Type A/C, Alfa Toxoid; Clostridium Perfringens Type A/C, Beta1 Toxoid; Clostridium Perfringens Type A/C, Beta2 Toxoid

Administration route:

Intramuscular use

Therapeutic group:

pig

Therapeutic area:

Clostridium

Product summary:

CTI code: 527706-02 - Pack size: 5 x 20 ml + 5 x 10 doses - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 527706-03 - Pack size: 10 x 20 ml + 10 x 10 doses - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 527706-01 - Pack size: 20 ml + 10 doses - Commercialisation status: NO - Delivery mode: Medical prescription

Authorization status:

Commercialised: No

Authorization date:

2018-03-27